Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma
Clinical trial NCT06124001 · UNKNOWN
Trial details
- NCT number
- NCT06124001
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2025-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.